ArticleHepatology communications2017

Potential epidemiologic, economic, and budgetary impacts of current rates of hepatitis C treatment in medicare and non-medicare populations.

John Wittenborn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.